Building A Global Network To Advance Neurodegenerative Disease Precision Medicine
AgenT works with leading clinical cohorts, academic centers, technology partners, laboratory networks, pharma and biotech companies, and innovation ecosystems to develop and validate blood-based tools for neurodegenerative diseases.
Through these collaborations, AgenT is building the evidence, infrastructure, and partnerships needed to support earlier detection, patient stratification, treatment development, and future clinical adoption.